Compound Genetically Engineered Mouse Models of Cancer Reveal Dual Targeting of ALK1 and Endoglin as a Synergistic Opportunity to Impinge on Angiogenic TGF-β Signaling
Oncotarget - United States
doi 10.18632/oncotarget.12604
Full Text
Open PDFAbstract
Available in full text
Categories
Date
October 12, 2016
Authors
Publisher
Impact Journals, LLC